Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin and Doxycycline in Mild COVID-19
NCT04551755Phase 2Unknown
- Sponsor
- Bangladesh Medical Research Council
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Ivermectin + Doxycycline Arm with Placebo Arm (2 arms). Primary endpoints: Time to outcome measure of fever (<100.4F) and cough at 10 days and Negative RT-PCR test on day 5 of treatment at 10 days. Status: unknown.
02
Drugs
ivermectindoxycycline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04551755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04551755.